Welcome to NDF Research
  • Introducing NDF
  • About us
    • About our Senior Analyst
    • Disclaimer relating to research and web content
    • Financial Services Guide and General Advice Warning
  • What we do
    • The Rise of the New Analysts
    • MiFID II
  • Our sector
    • ASX-Listed Life Science companies we watch >
      • ASX-listed Life Science companies, >$200m
      • ASX-listed Life Science companies, $100-200m
    • About Australia and Australians
    • Australia and the Life Sciences
    • Life Sciences in New Zealand >
      • Building the New Zealand Life Sciences sector
    • A tour of Life Sciences Down Under
    • Australia's global competitiveness in Life Sciences >
      • Australia's Life Sciences Innovation Rating
      • Australia's Life Sciences clusters
      • Australia's World-Class Universities
      • Australia's Nobel Laureates
      • Australia's public policy support for Life Sciences
      • Australia's support for women in Life Sciences
    • The Coming Boom in Australian Life Sciences >
      • Welcome to Australia's Life Sciences Boom
    • Key organisations in the Life Science sector in Australia and New Zealand
    • Notable people in the Life Sciences sector in Australia and New Zealand >
      • Great CEOs
      • 2017 Red Hat Award Winners
      • 2018 Red Hat Award Winners
      • 2019 Red Hat Award Winners
    • The NDF Life Sciences Index >
      • 2016-2017 Year in Review
  • Our clients
  • Contact us
    • linkedin
    • Twitter
    • NDF Research Youtube Channel
  • Latest research
    • Comprehensive update reports
    • Shorter update reports
    • Initiation reports >
      • Admedus
      • Invion
    • Media and interviews
    • Presentations
    • Previous research and media, 2003-2015
    • A Brief History of the Life Sciences in Australia
    • In our library
    • Intellectual property >
      • Australian PCT patent applications
      • New Zealand PCT patent applications
      • PCT patent applications, last twelve months >
        • 2017 PCT patent applications
        • 2016 PCT patent applications
        • 2015 PCT patent applications
        • 2014 PCT patent applications
        • 2013 PCT patent applications
      • US patents >
        • 2017 US patents
        • 2016 US patents
        • 2015 US patents
        • 2014 US patents
    • Publications
    • Glossary
    • Global Life Science companies to watch
  • Blog
Media and interviews from August 2016
Compiled by Stuart Roberts, Senior Analyst, stuart@ndfresearch.com, +61 447 247 909
10 August 2016 op-ed piece in The Life Sciences Report. This article, headlined 'The ASX: Investing in an Emerging Biotech Frontier',  was written just after I got back from Bioshares 2016 and not long after I had done an analysis of Australia's competitiveness in Life Sciences vis-à-vis the other powers in the field such as the UK and Germany (click here for that work).  
19 August 2016 podcast with Tom Orr at Bellmont Securities. In this interview I discuss our recent report on ResApp Health (ASX: RAP) as well as my contention that sometime in the next few years we could potentially enjoy a full-blown speculative boom in Life Sciences stocks here in Australia. Click here to listen to Tom's podcast. For background reading you might also enjoy an article I published in July 2016 entitled The Coming Boom in Australian Life Sciences.

22 August 2016 interview at Livewire with Adam Allcock of Katana Asset Management  and Andy Gracey of Australian Ethical. In this interview Adam, Andy and I discuss the July 2016 Bioshares meeting in New Zealand. Click here for that interview.

29 August 2016 article in The Australian. Tim Boreham of the Criterion column quotes NDF Research on why the medical devices sector of the Australian capital market has been offering good returns. The article is headlined Medical devices could cure your financial ills.

5 September 2016 article in the Sydney Morning Herald. Brian Robins has written a great article on James Williams' approach to building value with the companies he is involved with. I get quoted from my recent Dimerix report. Brian has headlined his piece James Williams' investors have made millions and now the focus is on whether he can do it again.

7 September 2016 interview with Livewire exclusive. In this video interview I discuss ImpediMed (ASX: IPD), which is commercialising a lymphedema diagnostic. Click here.

14 September 2016 interview with Livewire exclusive. In this video interview I discuss Sirtex (ASX: SRX), which is rapidly growing its SIR-Spheres brachytherapy for the treatment of liver cancer. Click here.

27 September 2016 interview with Livewire exclusive. In this video interview I discuss Mesoblast (ASX: MSB), the world's leading stem cell company. Click here.

5 June 2018 Sydney Morning Herald article on Sam Cobb, CEO of AdAlta (ASX: 1AD). This article quotes from some late 2017 work we did on women in leadership in the Life Sciences. Click here.

Copyright © 2016 NDF Research
Proudly powered by Weebly
  • Introducing NDF
  • About us
    • About our Senior Analyst
    • Disclaimer relating to research and web content
    • Financial Services Guide and General Advice Warning
  • What we do
    • The Rise of the New Analysts
    • MiFID II
  • Our sector
    • ASX-Listed Life Science companies we watch >
      • ASX-listed Life Science companies, >$200m
      • ASX-listed Life Science companies, $100-200m
    • About Australia and Australians
    • Australia and the Life Sciences
    • Life Sciences in New Zealand >
      • Building the New Zealand Life Sciences sector
    • A tour of Life Sciences Down Under
    • Australia's global competitiveness in Life Sciences >
      • Australia's Life Sciences Innovation Rating
      • Australia's Life Sciences clusters
      • Australia's World-Class Universities
      • Australia's Nobel Laureates
      • Australia's public policy support for Life Sciences
      • Australia's support for women in Life Sciences
    • The Coming Boom in Australian Life Sciences >
      • Welcome to Australia's Life Sciences Boom
    • Key organisations in the Life Science sector in Australia and New Zealand
    • Notable people in the Life Sciences sector in Australia and New Zealand >
      • Great CEOs
      • 2017 Red Hat Award Winners
      • 2018 Red Hat Award Winners
      • 2019 Red Hat Award Winners
    • The NDF Life Sciences Index >
      • 2016-2017 Year in Review
  • Our clients
  • Contact us
    • linkedin
    • Twitter
    • NDF Research Youtube Channel
  • Latest research
    • Comprehensive update reports
    • Shorter update reports
    • Initiation reports >
      • Admedus
      • Invion
    • Media and interviews
    • Presentations
    • Previous research and media, 2003-2015
    • A Brief History of the Life Sciences in Australia
    • In our library
    • Intellectual property >
      • Australian PCT patent applications
      • New Zealand PCT patent applications
      • PCT patent applications, last twelve months >
        • 2017 PCT patent applications
        • 2016 PCT patent applications
        • 2015 PCT patent applications
        • 2014 PCT patent applications
        • 2013 PCT patent applications
      • US patents >
        • 2017 US patents
        • 2016 US patents
        • 2015 US patents
        • 2014 US patents
    • Publications
    • Glossary
    • Global Life Science companies to watch
  • Blog